Advertisement
He is the new Chief Medical Officer at FluoGuide
Jens Ellrich, a German physician and medical scientist, brings experience in translational neuroscience, medical devices, biotechnology, pharmacology, and digital therapeutics.
His track record spans both academia and the start-up ecosystem, where he has advanced medical solutions across drugs, devices, and their combinations. He has played a key role in the development and launch of therapies at international companies such as the start-up Sapiens Steering Brain Stimulation acquired by Medtronic.
“His extensive experience in the biotech industry, particularly in advancing innovative therapies from concept to market, makes him an invaluable addition to FluoGuide. His expertise will be instrumental as we move into the critical phase of late-stage clinical trials and prepare for the commercialization of FG001 and will help ensure that our technology reaches its full potential in improving surgical outcomes for patients with cancers,” says Morten Albrechtsen, CEO, FluoGuide.
Updated: October 11, 2024, 08:08 am
Published: October 4, 2024
Advertisement